AstraZeneca
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Employees
- 89.9K
- Market Cap
- $270.3B
- Website
- http://www.astrazeneca.co.uk
- Introduction
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
A Study to Assess the Safety and Efficacy of AZD7789 in Participants With Advanced or Metastatic Solid Cancer
Phase 1
Active, not recruiting
- Conditions
- Carcinoma, Non-Small-Cell LungGastric CancerGastroesophageal Junction Cancer
- Interventions
- First Posted Date
- 2021-06-18
- Last Posted Date
- 2025-04-10
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 136
- Registration Number
- NCT04931654
- Locations
- 🇹🇷
Research Site, Karsiyaka, Turkey
Exacerbations and Their Outcomes International (EXACOS International)
Completed
- Conditions
- Chronic Obstructive Pulmonary Disease
- First Posted Date
- 2021-06-16
- Last Posted Date
- 2023-10-18
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 1762
- Registration Number
- NCT04928417
- Locations
- 🇨🇳
Research Site, Taoyuan City, Taiwan
Efficacy and Safety of Selumetinib in Adults With NF1 Who Have Symptomatic, Inoperable Plexiform Neurofibromas
Phase 3
Active, not recruiting
- Conditions
- Neurofibromatosis 1Plexiform Neurofibroma (PN)
- Interventions
- Other: Placebo
- First Posted Date
- 2021-06-14
- Last Posted Date
- 2024-12-09
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 146
- Registration Number
- NCT04924608
- Locations
- 🇬🇧
Research Site, Manchester, United Kingdom
The Impact of PCCM on Healthcare Among Asthma or Chronic Obstructive Pulmonary Disease (COPD) or Asthma-COPD Overlap Patients
Completed
- Conditions
- AsthmaCOPDAsthma-COPD Overlap
- First Posted Date
- 2021-05-27
- Last Posted Date
- 2024-07-31
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 288538
- Registration Number
- NCT04905420
- Locations
- 🇨🇳
Tianjin Chest Hospital, Tianjin, China
AMAZE™ Asthma Implementation QI Study
Completed
- Conditions
- Asthma
- Interventions
- Device: AMAZE™ Disease Management Platform
- First Posted Date
- 2021-05-25
- Last Posted Date
- 2022-08-01
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 117
- Registration Number
- NCT04901260
- Locations
- 🇺🇸
Research Site, Austin, Texas, United States
Phase I Double-blind, Placebo-controlled Study of AZD7442
Phase 1
Completed
- Conditions
- COVID-19
- Interventions
- Biological: AZD7442 300 mg IM(male)Biological: AZD7442 600 mg IM (male)Biological: AZD7442 300 mg IV (male and female)Biological: AZD7442 1000 mg IV (male)
- First Posted Date
- 2021-05-21
- Last Posted Date
- 2022-06-27
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 40
- Registration Number
- NCT04896541
- Locations
- 🇯🇵
Research Site, Fukuoka-shi, Japan
US PRECISION Implementation Study
Not Applicable
Completed
- Conditions
- Asthma
- Interventions
- Behavioral: AIRQBehavioral: Asthma ChecklistBehavioral: PRECISION Program (Educational Resources)
- First Posted Date
- 2021-05-19
- Last Posted Date
- 2023-06-01
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 857
- Registration Number
- NCT04891978
- Locations
- 🇺🇸
Research Site, Charleston, West Virginia, United States
Study to Evaluate the Effects of AZD3427 in Patients With Heart Failure
- First Posted Date
- 2021-05-18
- Last Posted Date
- 2021-12-17
- Lead Sponsor
- AstraZeneca
- Registration Number
- NCT04890548
LYNPARZA Pancreas Cancer Japan Post-Marketing Surveillance (PMS)
Completed
- Conditions
- Pancreatic Neoplasms
- First Posted Date
- 2021-05-17
- Last Posted Date
- 2025-04-15
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 130
- Registration Number
- NCT04889404
- Locations
- 🇯🇵
Research Site, Yamagata, Japan
D9319C00001- 1L OC Mono Global RCT
Phase 3
Active, not recruiting
- Conditions
- Ovarian Cancer
- Interventions
- Other: Matching placebo
- First Posted Date
- 2021-05-13
- Last Posted Date
- 2024-11-08
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 366
- Registration Number
- NCT04884360
- Locations
- 🇻🇳
Research Site, Ho Chi Minh, Vietnam
© Copyright 2025. All Rights Reserved by MedPath